Greenland Mines Ltd. (NASDAQ: GRML) has finalized the acquisition of the Sarfartoq Nd-Pr Rare Earths Project in southwest Greenland, a strategic move that could reshape the global supply chain for neodymium-praseodymium (NdPr) oxide outside China. The transaction, valued at $20 million in cash and $15 million in securities, closed on September 1, 2026, according to a company announcement.
The Sarfartoq project is designed to produce NdPr oxide annually at levels equivalent to approximately 34% of all NdPr oxide refined outside China at 2025 consumption rates, for each of its nine scheduled operating years. This output is critical given that NdPr is a key input for permanent magnets used in electric vehicles, wind turbines, and other clean energy technologies. With China dominating global rare earth processing, the project represents a significant step toward diversifying supply chains.
An independent Initial Assessment based solely on the ST1 deposit estimates a high-case pre-tax net present value of approximately $2.05 billion and a pre-tax internal rate of return of 118.6%, including Indicated and Inferred Mineral Resources. These figures underscore the project’s economic viability and its potential to attract further investment.
With the acquisition complete, Greenland Mines is advancing Sarfartoq toward a Pre-Feasibility Study. Planned activities include targeted infill drilling, pilot-scale metallurgical test work, mine engineering planning, environmental and social baseline studies, and drone-based magnetic surveys. These steps are essential to de-risk the project and refine its technical and economic parameters.
The transaction also brings Neo Performance Materials (TSX: NEO) on board as a strategic shareholder. Neo retains offtake rights for up to 60% of future Sarfartoq ore or mineral concentrate production, which will be processed at its Silmet rare earth separation facility in Estonia. This partnership ensures a ready market for Sarfartoq’s output and strengthens the project’s integration into Western supply chains.
Greenland Mines operates with two divisions: Mining, which focuses on the Skaergaard Project in southeast Greenland and now Sarfartoq; and Biotech, which includes Klotho’s KLTO-202 primary indication for ALS. The company’s strategy is to build a multi-asset platform with exposure to rare earth magnet materials, precious metals, and selected midstream processing opportunities, while advancing its broader North Atlantic Critical Metals Corridor vision. This corridor aims to link Greenland resources with allied downstream jurisdictions and industrial infrastructure.
Investors and industry observers are watching closely as Greenland Mines moves Sarfartoq forward. The project’s scale and its role in providing non-Chinese NdPr supply could make it a cornerstone in the global transition to cleaner energy technologies. For more details, the full press release is available at https://ibn.fm/rTIg0.
